T. Ubhi, Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy, Archives of Disease in Childhood, vol.83, issue.6, pp.481-488, 2000.
DOI : 10.1136/adc.83.6.481

D. H. Sutherland, Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy, Gait & Posture, vol.10, issue.1, pp.1-9, 1999.
DOI : 10.1016/S0966-6362(99)00012-0

L. A. Koman, Management of Spasticity in Cerebral Palsy with Botulinum-A Toxin: Report of a Preliminary, Randomized, Double-Blind Trial, Journal of Pediatric Orthopaedics, vol.14, issue.3, pp.299-303, 1994.
DOI : 10.1097/01241398-199405000-00005

J. Kirschner, Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option, Journal of Neurology, vol.248, issue.S1, pp.28-30, 2001.
DOI : 10.1007/PL00007815

L. A. Koman, P. Smith, B. Balkrishnan, and R. , Spasticity Associated with Cerebral Palsy in Children, Pediatric Drugs, vol.33, issue.1, pp.11-23, 2003.
DOI : 10.2165/00128072-200305010-00002

L. A. Koman, Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Equinus Foot Deformity in Cerebral Palsy: A Multicenter, Open-Label Clinical Trial, PEDIATRICS, vol.108, issue.5, pp.1062-71, 2001.
DOI : 10.1542/peds.108.5.1062

E. S. Cardoso, Botulinum Toxin Type A for the Treatment of the Spastic Equinus Foot in Cerebral Palsy, Pediatric Neurology, vol.34, issue.2, pp.106-115, 2006.
DOI : 10.1016/j.pediatrneurol.2005.08.010

H. Bertrand and V. Forin, Toxine botulinique type A chez l???enfant : ??valuation des indications ?? partir d???une revue de la litt??rature, Annales de R??adaptation et de M??decine Physique, vol.46, issue.6, pp.346-52, 2003.
DOI : 10.1016/S0168-6054(03)00107-7

R. N. Boyd and R. M. Hays, Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH-2 approach, European Journal of Neurology, vol.127, issue.s5, pp.167-77, 2001.
DOI : 10.1093/jpepsy/25.6.381

G. Sheean, The pathophysiology of spasticity, European Journal of Neurology, vol.9, issue.s1, pp.3-9, 2002.
DOI : 10.1016/S0022-510X(00)00299-9

M. Galli, Computerized gait analysis of Botulinum Toxin treatment in children with cerebral palsy, Disability and Rehabilitation, vol.70, issue.8, pp.659-64, 2007.
DOI : 10.1097/01241398-199307000-00013

A. M. Glanzman, Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis, Dev Med Child Neurol, issue.12, pp.46-807, 2004.

A. Schwerin, Botulinum toxin B treatment in children with spastic movement disorders: A pilot study, Pediatric Neurology, vol.31, issue.2, pp.109-122, 2004.
DOI : 10.1016/j.pediatrneurol.2003.12.016

D. J. Russell, THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY, Developmental Medicine & Child Neurology, vol.83, issue.3, pp.31-341, 1989.
DOI : 10.1111/j.1469-8749.1989.tb04003.x

M. Gough, P. Schneider, and S. A. , The outcome of surgical intervention for early deformity in young ambulant children with bilateral spastic cerebral palsy, Journal of Bone and Joint Surgery - British Volume, vol.90, issue.7, pp.90-946, 2008.
DOI : 10.1302/0301-620X.90B7.20577

P. Manganotti, Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy, Journal of Rehabilitation Medicine, vol.39, issue.2, pp.115-135, 2007.
DOI : 10.2340/16501977-0036

B. Dohin, Le traitement de la spasticité. Dans L'infirme moteur cérébral marchant. De l'annonce du handicap à la prise en charge de l'adulte, E.S. medical, pp.125-141, 2005.

P. Filipetti, C. Caldas, and Y. Delpierre, Avanc??es dans??le??traitement de??la??spasticit?? et??enfant IMOC, Archives de P??diatrie, vol.13, issue.6, pp.614-619, 2006.
DOI : 10.1016/j.arcped.2006.03.089

L. A. Koman, B. P. Smith, and S. J. , Cerebral palsy, The Lancet, vol.363, issue.9421, pp.1619-1650, 2004.
DOI : 10.1016/S0140-6736(04)16207-7

A. Quesnot, Analyse de la marche de l'enfant présentant une hémiplégie cérébrale infantile et logigramme de prise en charge, 2003.

H. K. Graham, Recommendations for the use of botulinum toxin type A in the management of cerebral palsy, Gait & Posture, vol.11, issue.1, pp.67-79, 2000.
DOI : 10.1016/S0966-6362(99)00054-5

G. Molenaers, Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences, European Journal of Neurology, vol.10, issue.s5, pp.88-97, 2001.
DOI : 10.1016/0966-6362(95)01054-8

H. K. Graham, Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy, European Journal of Neurology, vol.26, issue.s5, pp.30-39, 2001.
DOI : 10.1017/S0012162299000018

M. E. Gormley, Non operative treatment., in The treatment of gait problems in cerebral palsy, pp.245-72, 2004.

G. Rode, Medical treatment of spasticity, Neurochirurgie, vol.49, issue.2 2, pp.247-55, 2003.

J. M. Gracies, Physiological effects of botulinum toxin in spasticity, Movement Disorders, vol.31, issue.S8, pp.120-128, 2004.
DOI : 10.1002/mds.20065

Y. Kirazli, COMPARISON OF PHENOL BLOCK AND BOTULINUS TOXIN TYPE A IN THE TREATMENT OF SPASTIC FOOT AFTER STROKE, American Journal of Physical Medicine & Rehabilitation, vol.77, issue.6, pp.77-510, 1998.
DOI : 10.1097/00002060-199811000-00012

K. Buffenoir, Spastic Equinus Foot: Multicenter Study of the Long-term Results of Tibial Neurotomy, Neurosurgery, vol.55, issue.5, pp.1130-1137, 2004.
DOI : 10.1227/01.NEU.0000140840.59586.CF

A. Feve, Physiological effects of selective tibial neurotomy on lower limb spasticity, Journal of Neurology, Neurosurgery & Psychiatry, vol.63, issue.5, pp.575-583, 1997.
DOI : 10.1136/jnnp.63.5.575

P. Lebarbier, Place de??la??chirurgie dans??la??prise en??charge de??l'infirmit?? motrice d'origine c??r??brale, Archives de P??diatrie, vol.13, issue.6, pp.615-622, 2006.
DOI : 10.1016/j.arcped.2006.03.037

J. Bérard, Techniques chirugicales, in L'infirme moteur cérébral marchant. De l'annonce du handicap à la prise en charge de l', pp.160-161, 2005.

S. Sangla, Aspects thérapeutiques actuels de la toxine botulique en neurologie, EMC, pp.17-066, 2006.
DOI : 10.1016/s1283-0887(07)48907-1

F. J. Erbguth and M. Naumann, Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison", Neurology, vol.53, issue.8, pp.53-1850, 1999.
DOI : 10.1212/WNL.53.8.1850

B. Poulain and Y. Humeau, Le mode d???action des neurotoxines botuliques : aspects pathologiques, cellulaires et mol??culaires, Annales de R??adaptation et de M??decine Physique, vol.46, issue.6, pp.265-75, 2003.
DOI : 10.1016/S0168-6054(03)00114-4

M. H. Marion, Dose standardisation of botulinum toxin., Journal of Neurology, Neurosurgery & Psychiatry, vol.59, issue.1, pp.102-105, 1995.
DOI : 10.1136/jnnp.59.1.102

A. M. Pickett and P. Hambleton, Dose standardisation of botulinum toxin, The Lancet, vol.344, issue.8920, pp.344-474, 1994.
DOI : 10.1016/S0140-6736(94)91806-6

D. Ranoux, Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia, J Neurol Neurosurg Psychiatry, vol.72, issue.4, pp.459-62, 2002.

F. Heinen, European consensus table 2006 on botulinum toxin for children with cerebral palsy, European Journal of Paediatric Neurology, vol.10, issue.5-6, pp.5-6, 2006.
DOI : 10.1016/j.ejpn.2006.08.006

J. Houltram, Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation, European Journal of Neurology, vol.28, issue.s5, pp.194-202, 2001.
DOI : 10.1016/S0966-6362(99)00054-5

M. Naumann, Safety and efficacy of botulinum toxin type A following long-term use, European Journal of Neurology, vol.22, issue.5, pp.35-40, 2006.
DOI : 10.1007/s004150050345

M. Z. Atassi, Basic immunological aspects of botulinum toxin therapy, Movement Disorders, vol.9, issue.S8, pp.68-84, 2004.
DOI : 10.1002/mds.20020

D. Dressler, Clinical presentation and management of antibody-induced failure of botulinum toxin therapy, Movement Disorders, vol.45, issue.S8, pp.92-100, 2004.
DOI : 10.1002/mds.20022

S. Berweck and F. Heinen, Use of botulinum toxin in pediatric spasticity

J. M. Fève, Immunisation à la toxine botulique, pp.9-11, 1999.

C. Vial, Les toxines botuliques. Mode d'action et perspectives thérapeutiques Journée nationale d'étude sur les injections de toxine botulique chez l'enfant IMC, pp.13-16, 2004.

K. W. Nolan, L. L. Cole, and L. G. , Use of botulinum toxin type A in children with cerebral palsy, Phys Ther, vol.86, issue.4, pp.573-84, 2006.

A. P. Cosgrove, I. S. Corry, and G. H. , BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY, Developmental Medicine & Child Neurology, vol.26, issue.5, pp.386-96, 1994.
DOI : 10.1111/j.1469-8749.1994.tb11864.x

F. J. Ruiz, Costs and consequences of botulinum toxin type A use, The European Journal of Health Economics, formerly: HEPAC, vol.82, issue.3, pp.227-262, 2004.
DOI : 10.1007/s10198-004-0224-7

H. Bertrand, La marche sur la pointe des pieds. Pédiatrie, pp.25-29, 2004.

B. Parratte and G. Metton, Repères anatomiques avant et au cours d'injections de toxine botulique, in Journée nationale d'étude sur les injections de toxine botulique chez l'enfant IMC, pp.23-26, 2004.

M. Gough, C. Fairhurst, and S. A. , Botulinum toxin and cerebral palsy: time for reflection? Dev Med Child Neurol, pp.47-709, 2005.

L. Wiart, Evaluation clinique de l'efficacité de la toxine botulique. Proposition d'une nouvelle grille d'évaluation rapide

K. Bjornson, Botulinum Toxin for Spasticity in Children With Cerebral Palsy: A Comprehensive Evaluation, PEDIATRICS, vol.120, issue.1, pp.49-58, 2007.
DOI : 10.1542/peds.2007-0016

M. A. Hoving, Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A randomised controlled trial, European Journal of Paediatric Neurology, vol.13, issue.3, 2008.
DOI : 10.1016/j.ejpn.2008.04.013

M. Rousseaux and W. Daveluy, The risk-benefit of high doses of botulinum toxin injections for muscle spasticity Ann Readapt Med Phys, pp.1-3, 2007.

P. Filipetti and F. Chantraine, Utilisation de fortes doses de toxine botulique de type A chez l'enfant: int??r??t et s??curit?? en pratique clinique, Annales de R??adaptation et de M??decine Physique, vol.50, issue.1, pp.7-11, 2007.
DOI : 10.1016/S0168-6054(07)80003-1

K. Desloovere, A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures, European Journal of Neurology, vol.30, issue.s5
DOI : 10.1016/0966-6362(95)01054-8

D. W. Rha, Is Electrical Stimulation Beneficial for Improving the Paralytic Effect of Botulinum Toxin Type A in Children with Spastic Diplegic Cerebral Palsy?, Yonsei Medical Journal, vol.49, issue.4, pp.545-52, 2008.
DOI : 10.3349/ymj.2008.49.4.545